Key facts
- This page summarizes Adrian Miranda's Form 4 filing for Neuraxis, INC (NRXS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Aug 2026, 18:36.
Adrian Miranda - 13 Aug 2026 Form 4 Insider Report for Neuraxis, INC (NRXS)
- Reporting relationship
- CMO, SVP Science & Tech
- Issuer ticker
- NRXS
- Reported as of
- 13 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Aug 2026, 18:36:02 UTC
- Prior SEC filing
- 02 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Adrian Miranda
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Adrian Miranda filed Form 4 for Neuraxis, INC (NRXS) on 17 Aug 2026.
Change
- Previous filing in this sequence was filed on 02 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001992525
Primary reporting owner
Miranda Adrian
- Relationship
- CMO, SVP Science & Tech
- Address
- 11611 N. MERIDIAN ST,, SUITE 330, CARMEL
- Signature
- /s/ Adrian Miranda
- Signature date
- 17 Aug 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NRXS
transaction
Derivative
RSU
Award
- Transaction value
- Shares
- +133,341
- Change %
- Price
- $6.28*
- Shares after
- 133,341
- Date
- 13 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 133,341
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period.